JPM25: GSK, Sanofi CEOs welcome 'transparency' in response to anti-vaccine movement in US

The anti-vaccine movement in the U.S. has gained momentum with President-elect Donald Trump's nomination of Robert F. Kennedy Jr. to run the Department of Health and Human Services.

How do Sanofi CEO Paul Hudson and GSK CEO Emma Walmsley—who lead two of the top vaccine companies in the world—feel about the movement and how it could affect their businesses?